0000899243-19-008139.txt : 20190318
0000899243-19-008139.hdr.sgml : 20190318
20190318162347
ACCESSION NUMBER: 0000899243-19-008139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190314
FILED AS OF DATE: 20190318
DATE AS OF CHANGE: 20190318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuwahara Jon
CENTRAL INDEX KEY: 0001664784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 19688528
MAIL ADDRESS:
STREET 1: 21250 HAWTHORNE BOULEVARD
STREET 2: SUITE 800
CITY: TORRANCE
STATE: CA
ZIP: 90503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-14
0
0001404281
Novus Therapeutics, Inc.
NVUS
0001664784
Kuwahara Jon
C/O NOVUS THERAPEUTICS, INC.
19900 MACARTHUR BLVD., SUITE 550
IRVINE
CA
92612
0
1
0
0
See Remarks
Stock Option (Right to Buy)
3.72
2019-03-14
4
A
0
25000
0.00
A
2029-03-14
Common Stock
25000
25000
D
This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Senior Vice President of Finance and Administration
/s/ Ryan A. Murr, as attorney-in-fact for Jon Kuwahara
2019-03-18